Tranexamic Acid to Reduce Blood Loss in Transurethral Resection of Prostate

Single Intravenous Bolus versus Continuous Infusion of Tranexamic Acid to Reduce Blood Loss in Transurethral Resection of Prostate: a Prospective Randomized Double-Blind Study

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

PACTR

Registry ID

PACTR202407652050074

Enrollment

Registered

2024-07-10

Start date

2019-09-16

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Haematological Disorders Surgery Urological and Genital Diseases Anaesthesia

Interventions

A single bolus of tranexamic acid

An infusion of tranexemic acid

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Patients with an ASA I / II classification undergoing elective TURP.

Exclusion criteria

Exclusion criteria: History of bleeding diathesis Pulmonary embolism DVT A known allergy to TXA or Having any contraindications for spinal anesthesia

Design outcomes

Primary

Measure	Time frame
Perioperative blood loss and need for allogeneic blood transfusion	—

Secondary

Measure	Time frame
Assess the postoperative hemoglobin (Hb), hematocrit (Hct) value ;incidence of Deep venous thrombosis	—

Countries

Egypt

Contacts

Public ContactMarwa Elbeialy

Associate Professor

marwaelbeialy@gmail.com01006518802

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026